$5.84
▲ +0.3% Today
as of Sep 4, 16:45 ET
Last 30 days
Recent Press Releases & News
Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials
Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
Armata Pharmaceuticals (ARMP) Stock Jumps 12.2%: Will It Continue to Soar?
Overview
52-week range
$2.76
$16
23% of range
Avg surprise (last 2)
+32.7%
Avg reaction (last 2)
-2.4%
0% positive
Latest IV / EM
203%
EM ±31.7% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.27 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.39 | — | — | -95.0% | -2.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.74 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.32 | $-0.39 | +17.9% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.20 | $-0.38 | +47.4% | — | -2.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.15 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.25 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.69 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.86 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.17 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.40 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-10M | $-9M | — | $-8M | $-7M | $-8M | — | $-10M |
| Net income | $74M | $-115M | — | $-27M | $-16M | $-7M | — | $-5M |
| EPS (diluted) | $-0.27 | $-3.16 | — | $-0.74 | $-0.45 | $-0.20 | — | $-0.15 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $24M | $5M | $9M | $15M | $4M | $12M | $9M | $17M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $27M | $6M | $11M | $17M | $8M | $13M | $11M | $22M |
| Total assets | $90M | $70M | $77M | $90M | $81M | $87M | $86M | $98M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $321M | $381M | $295M | $185M | $150M | $141M | $134M | $149M |
| Total equity | $-231M | $-312M | $-219M | $-96M | $-70M | $-54M | $-48M | $-51M |